KSE - Delayed Quote KRW

JW Holdings Corporation (096760.KS)

Compare
3,025.00 +40.00 (+1.34%)
At close: January 3 at 3:30:27 PM GMT+9
Loading Chart for 096760.KS
DELL
  • Previous Close 2,985.00
  • Open 2,985.00
  • Bid 3,025.00 x --
  • Ask 3,050.00 x --
  • Day's Range 2,970.00 - 3,035.00
  • 52 Week Range 2,650.00 - 3,905.00
  • Volume 75,544
  • Avg. Volume 59,931
  • Market Cap (intraday) 213.953B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 3, 2025 - Feb 7, 2025
  • Forward Dividend & Yield 105.00 (3.58%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est --

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment, operating room equipment, non-PVC film, tube, and empty bag, and health supplements. In addition, the company provides integrated services for IV solution. JW Holdings Corporation was founded in 1945 and is based in Gwacheon-si, South Korea.

www.jw-holdings.co.kr

136

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 096760.KS

View More

Performance Overview: 096760.KS

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

096760.KS
0.17%
KOSPI Composite Index
1.77%

1-Year Return

096760.KS
7.44%
KOSPI Composite Index
6.34%

3-Year Return

096760.KS
2.54%
KOSPI Composite Index
17.99%

5-Year Return

096760.KS
38.69%
KOSPI Composite Index
12.20%

Compare To: 096760.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 096760.KS

View More

Valuation Measures

Annual
As of 1/3/2025
  • Market Cap

    213.95B

  • Enterprise Value

    521.81B

  • Trailing P/E

    3.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    1.31

  • Enterprise Value/Revenue

    0.56

  • Enterprise Value/EBITDA

    2.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.30%

  • Return on Assets (ttm)

    7.87%

  • Return on Equity (ttm)

    26.09%

  • Revenue (ttm)

    915.74B

  • Net Income Avi to Common (ttm)

    57.68B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    155.59B

  • Total Debt/Equity (mrq)

    132.02%

  • Levered Free Cash Flow (ttm)

    58.31B

Research Analysis: 096760.KS

View More

Company Insights: 096760.KS

Research Reports: 096760.KS

View More

People Also Watch